Montreal Public Health has issued a warning about a recent increase in overdoses linked to the use of alleged counterfeit Dilaudid. According to the health agency, there have been several cases reported in the city’s downtown area.
Dilaudid, also known as hydromorphone, is a powerful opioid pain medication commonly used to treat severe pain. However, the alleged counterfeit version of the drug has been found to contain fentanyl, a highly potent synthetic opioid that can be fatal in small doses.
The health agency is urging individuals who use Dilaudid to be cautious and to only obtain the medication from a legitimate source, such as a pharmacy. They also advise individuals to be aware of the signs of an overdose, which include difficulty breathing, extreme drowsiness, and loss of consciousness.
In addition, Montreal Public Health is working closely with local law enforcement to investigate the source of the counterfeit Dilaudid and to prevent its distribution. They are also reminding the public that the use of any illicit drugs, including counterfeit medications, is illegal and can have serious consequences.
This warning comes as Montreal continues to battle a growing opioid crisis. In 2020, there were 1,164 opioid-related deaths in the city, a 46% increase from the previous year. The pandemic has only exacerbated the issue, with many individuals turning to drugs as a coping mechanism for stress and isolation.
Montreal Public Health is urging individuals struggling with substance abuse to seek help and support. They recommend contacting the Quebec Addiction Help and Referral Centre at 1-800-265-2626 for assistance.
The health agency’s warning serves as a reminder of the dangers of counterfeit drugs and the importance of obtaining medication from a legitimate source. It also highlights the ongoing need for education and resources to address the opioid crisis in Montreal and beyond.
